This means 20% of patients do not survive year one and 35% do not live past 3 years. So the good news is that if you make it to 3 years, each additional year death is less likely. High risk patients have had an average life expectancy of 2 years. But at 3 years this would only have an impact of approximately 11.25% or less than 1/3 of the total impact of 35% three year death rate of myeloma patients. Late diagnosis and other factors represent 1 in 5 patients or 20% die in the first 2 months based on the Myeloma UK data. A great You Tube video by Myeloma UK is below. The US rate must be a little bit lower because our one year rate is between 19 and 20%.
So the sky is the limit if we can just find myeloma in the precursor state, monitor it, and treat it early! That will be the key to extending life expectancy and potentially cure! In addition, finding an effective high risk myeloma therapy or cure is the ultimate end game.